Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 65, Issue 6, 2006, Pages 791-795

  Orozco, G ^a   Sanchez E ^a   Gomez L M ^b   Gonzalez Gay M A ^c   Lopez Nevot M A ^d   Torres, B ^e   Ortego Centeno, N ^f   Jimenez Alonso J ^d   De Ramon E ^g   Sanchez Roman J ^e   Anaya, J M ^h   Sturfelt, G ⁱ   Gunnarsson, I ^j   Svennungsson, E ^j   Alarcon Riquelme M ^k   Gonzalez Escribano M F ^e   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c HOSPITAL XERAL CALDE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h UNIVERSIDAD DEL ROSARIO   (Colombia)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k UPPSALA UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN SLC22A4; SUMO PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; COLOMBIA; CONTROLLED STUDY; DISEASE SEVERITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEPHRITIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ODDS RATIO; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 33744504186     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.044891     Document Type: Article

References (19)

1. Tsoo BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595-602.
2. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non- MHC susceptibility genes. Nat Immunol 2001;2:802-9.
3. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001;7:899-905.
4. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-11.
5. Siminovitch KA. PTPN22 and autoimmune disease. Nat Genet 2004;36:1248-9.
6. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003;35:341-8.
7. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002;32:666-9.
8. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003;35:349-56.
9. Peltekova VD, Wintle RF, Rubin IA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004;36:471-5.
10. Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004;36:837-41.
11. Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 2004;279:27233-8.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-21.
14. Owerbach D, Pina L, Gabbay KH. A 212-kb region on chromosome 6q25 containing the TAB2 gene is associated with susceptibility to type 1 diabetes. Diabetes 2004;53:1890-3.
15. Yamazaki K, Takazoe M, Tanaka T, Ichimori T, Saito S, Iida A, et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet 2004;49:664-8.
16. Smyth DJ, Howson JM, Lowe CE, Walker NM, Lam AC, Nutland S, et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet. 2005;37: 110-11; author's reply, 112-13.
17. Qu H, Bharaj B, Liu XQ, Curtis JA, Newhook LA, Paterson AD, et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet. 2005;37: 111-12; author's reply, 112-13.
18. Sakurai H, Hisada Y, Ueno M, Sugiura M, Kawashima K, Sugita T. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim Biophys Acta 1996;1316:132-8.
19. Tomita N, Morishita R, Lan HY, Yamamoto K, Hashizume M, Notake M, et al. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000;11:1244-52.